EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC0

Viral persistence, reactivation, and mechanisms of long COVID

Benjamin Chen iD, Boris Julg iD, Sindhu Mohandas iD, Steven B Bradfute iD, RECOVER Mechanistic Pathways Task Force

eLife · 04.05.2023 · 12

DOI: 10.7554/elife.86015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift eLife, online erschienen am 04.05.2023. Verfasst von Benjamin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals. Following COVID-19 infection, a subset can develop a wide range of chronic symptoms affecting diverse organ systems referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. A National Institutes of Health-sponsored initiative, RECOVER: Researching COVID to Enhance Recovery, has sought to understand the basis of long COVID in a large cohort. Given the range of symptoms that occur in long COVID, the mechanisms that may underlie these diverse symptoms may also be diverse. In this review, we focus on the emerging literature supporting the role(s) that viral persistence or reactivation of viruses may play in PASC. Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear. Understanding the mechanisms of persistence of RNA, antigen or other reactivated viruses and how they may relate to specific inflammatory responses that drive symptoms of PASC may provide a rationale for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Post-Acute COVID-19 SyndromeCOVID-19United StatesHumansRNA, ViralSARS-CoV-2Disease Progression

Stichwörter der Autor:innen

PASCReactivationSARS-CoV-2epidemiologyglobal healthimmunologyinflammationlong COVIDviral persistence

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Infectious Diseases Division, Massachusetts General Hospital, Ragon Institute of Mass General, MIT and Harvard, Boston, United States.
  • Division of Infectious Diseases, Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, United States.
  • Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, United States.

ORCID-Profile: Benjamin Chen, Boris Julg, Sindhu Mohandas, Steven B Bradfute

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Chen, B., Julg, B., Mohandas, S., Bradfute, S. B., & RECOVER Mechanistic Pathways Task Force (2023). Viral persistence, reactivation, and mechanisms of long COVID. eLife, 12. https://doi.org/10.7554/elife.86015

Vancouver

Chen B, Julg B, Mohandas S, Bradfute SB, RECOVER Mechanistic Pathways Task Force. Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12. doi:10.7554/elife.86015

BibTeX
@article{Chen2023,
  author = {Chen, Benjamin and Julg, Boris and Mohandas, Sindhu and Bradfute, Steven B and RECOVER Mechanistic Pathways Task Force, RECOVER Mechanistic Pathways Task Force},
  title = {Viral persistence, reactivation, and mechanisms of long COVID},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.86015}
}
Kostenlos starten →